HIM
AGTC

Hillsdale Investment Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Hillsdale Investment Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,100
Closed -$25K – 680
2019
Q3 		$25K Buy
+6,100
New +$22K ﹤0.01% 474
2019
Q1 		– Sell
-23,414
Closed -$58K – 709
2018
Q4 		$58K Buy
+23,414
New +$137K 0.01% 415

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hillsdale Investment Management's AGTC Position: Q4 2019 in Review

Hillsdale Investment Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2019, closing a stake of 6,100 shares — an estimated $25K sold.

Hillsdale Investment Management first reported a position in AGTC in Q4 2018 and held it in 2 quarters. The position peaked at $58K in Q4 2018. 52 funds tracked by Wall St. Rank hold AGTC as of Q4 2019.

  • Hillsdale Investment Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2019 after selling out during the quarter.
  • Hillsdale Investment Management sold 6,100 Applied Genetic Technologies Corporation shares in Q4 2019, an estimated $25K.
  • Hillsdale Investment Management first reported a position in Applied Genetic Technologies Corporation in Q4 2018 and held it in 2 quarters.
  • Hillsdale Investment Management's Applied Genetic Technologies Corporation position peaked at $58K in Q4 2018.
  • 52 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2019.

Based on Hillsdale Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.